scholarly journals Structure of phase III of solid hydrogen

2007 ◽  
Vol 3 (7) ◽  
pp. 473-476 ◽  
Author(s):  
Chris J. Pickard ◽  
Richard J. Needs
Keyword(s):  
Solid Hydrogen ◽  
Phase Iii

scholarly journals Hexagonal structure of phase III of solid hydrogen

2016 ◽  
Vol 94 (13) ◽  
Author(s):  
Bartomeu Monserrat ◽  
Richard J. Needs ◽  
Eugene Gregoryanz ◽  
Chris J. Pickard
Keyword(s):  
Solid Hydrogen ◽  
Hexagonal Structure ◽  
Phase Iii

scholarly journals Unconventional phase III of high-pressure solid hydrogen

2019 ◽  
Vol 100 (15) ◽  
Author(s):  
Sam Azadi ◽  
Thomas D. Kühne
Keyword(s):  
High Pressure ◽  
Solid Hydrogen ◽  
Phase Iii

scholarly journals The role of van der Waals and exchange interactions in high-pressure solid hydrogen

2017 ◽  
Vol 19 (32) ◽  
pp. 21829-21839 ◽  
Author(s):  
Sam Azadi ◽  
Graeme J. Ackland
Keyword(s):  
High Pressure ◽  
Molecular Hydrogen ◽  
Van Der Waals ◽  
Exchange Interactions ◽  
Solid Hydrogen ◽  
Van Der Waals Interactions ◽  
Phase Iii

Our study of the van der Waals interactions in solid molecular hydrogen structures indicates two candidates for phase III.

Symmetry Breaking in Dense Solid Hydrogen: Mechanisms for the Transitions to Phase II and Phase III

2009 ◽  
Vol 103 (10) ◽  
Author(s):  
Pierre Tolédano ◽  
Hannelore Katzke ◽  
Alexander F. Goncharov ◽  
Russell J. Hemley
Keyword(s):  
Symmetry Breaking ◽  
Phase Ii ◽  
Solid Hydrogen ◽  
Phase Iii

Evidence from x-ray diffraction of orientational ordering in phase III of solid hydrogen at pressures up to 183 GPa

2010 ◽  
Vol 82 (6) ◽  
Author(s):  
Yuichi Akahama ◽  
Manabu Nishimura ◽  
Haruki Kawamura ◽  
Naohisa Hirao ◽  
Yasuo Ohishi ◽  
...  
Keyword(s):  
Solid Hydrogen ◽  
Phase Iii ◽  
X Ray Diffraction ◽  
X Ray ◽  
Orientational Ordering

scholarly journals Raman scattering and x-ray diffraction experiments for phase III of solid hydrogen

2010 ◽  
Vol 215 ◽  
pp. 012056 ◽  
Author(s):  
Y Akahama ◽  
H Kawamura ◽  
N Hirao ◽  
Y Ohishi ◽  
K Takemura
Keyword(s):  
Raman Scattering ◽  
Solid Hydrogen ◽  
Phase Iii ◽  
X Ray Diffraction ◽  
X Ray

scholarly journals Raman scattering and X-ray diffraction studies on phase III of solid hydrogen

2017 ◽  
Vol 950 ◽  
pp. 042060 ◽  
Author(s):  
Y Akahama ◽  
Y Mizuki ◽  
S Nakano ◽  
N Hirao ◽  
Y Ohishi
Keyword(s):  
Raman Scattering ◽  
Solid Hydrogen ◽  
Phase Iii ◽  
X Ray Diffraction ◽  
X Ray

RTS,S/AS01, a vaccine targeting pre-erythrocytic stages of Plasmodium falciparum

2017 ◽  
Vol 1 (6) ◽  
pp. 533-537
Author(s):  
Lorenz von Seidlein ◽  
Borimas Hanboonkunupakarn ◽  
Podjanee Jittmala ◽  
Sasithon Pukrittayakamee
Keyword(s):  
Protective Efficacy ◽  
Age Groups ◽  
Sub Saharan Africa ◽  
Phase Iii ◽  
European Medicines Agency ◽  
Older Children ◽  
Pivotal Phase ◽  
Malaria Epidemiology ◽  
Maximum Benefit ◽  
Sub Saharan

RTS,S/AS01 is the most advanced vaccine to prevent malaria. It is safe and moderately effective. A large pivotal phase III trial in over 15 000 young children in sub-Saharan Africa completed in 2014 showed that the vaccine could protect around one-third of children (aged 5–17 months) and one-fourth of infants (aged 6–12 weeks) from uncomplicated falciparum malaria. The European Medicines Agency approved licensing and programmatic roll-out of the RTSS vaccine in malaria endemic countries in sub-Saharan Africa. WHO is planning further studies in a large Malaria Vaccine Implementation Programme, in more than 400 000 young African children. With the changing malaria epidemiology in Africa resulting in older children at risk, alternative modes of employment are under evaluation, for example the use of RTS,S/AS01 in older children as part of seasonal malaria prophylaxis. Another strategy is combining mass drug administrations with mass vaccine campaigns for all age groups in regional malaria elimination campaigns. A phase II trial is ongoing to evaluate the safety and immunogenicity of the RTSS in combination with antimalarial drugs in Thailand. Such novel approaches aim to extract the maximum benefit from the well-documented, short-lasting protective efficacy of RTS,S/AS01.

Rome I versus Rome II; Overlap in patients enrolled in tegaserod phase III clinical trials for irritable bowel syndrome (IBS)

2001 ◽  
Vol 120 (5) ◽  
pp. A284-A284
Author(s):  
B NAULT ◽  
S SUE ◽  
J HEGGLAND ◽  
S GOHARI ◽  
G LIGOZIO ◽  
...  
Keyword(s):  
Clinical Trials ◽  
Irritable Bowel Syndrome ◽  
Phase Iii ◽  
Phase Iii Clinical Trials ◽  
Irritable Bowel ◽  
Rome I
Sign in / Sign up

Export Citation Format

Share Document